Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rao

Showing results (721-730 of 733) with videos related to

Pageof 74
Sort By:
Mbio|July 28, 2022
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 VaccineJingen Zhu, Swati Jain, Jian Sha, et al.
Journal of Intellectual Disability Research : JIDR|July 25, 2009
Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilitiesP Oliver-Africano, S Dickens, Z Ahmed, et al.
Toxicologic Pathology|November 18, 2011
Proceedings of the 2011 National Toxicology Program Satellite SymposiumGary Boorman, Torrie A Crabbs, Holly Kolenda-Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2012
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemiaSmriti Khanna, Sandeep Burudkar, Komal Bajaj, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
European Journal of Pharmacology|February 26, 2009
A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitisNilesh M Dagia, Divya V Kamath, Pooja Bhatt, et al.
Scientific Reports|January 26, 2023
Oceanic SACZ produces an abnormally wet 2021/2022 rainy season in South AmericaLuciano P Pezzi, Mario F L Quadro, Everaldo B Souza, et al.
Genome Research|May 31, 2001
Genetic evidence on the origins of Indian caste populationsM Bamshad, T Kivisild, W S Watkins, et al.
Health Technology Assessment (Winchester, England)|April 29, 2009
Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)P Tyrer, P Oliver-Africano, R Romeo, et al.
Tissue Antigens|July 8, 2011
Characterization of 236 novel alleles at the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci from China Marrow Donor ProgramJ Li, J Qu, X Zhang, et al.
Pageof 74

Showing results (721-730 of 733) with videos related to

Sort By:
Pageof 74
Mbio|July 28, 2022
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 VaccineJingen Zhu, Swati Jain, Jian Sha, et al.
Journal of Intellectual Disability Research : JIDR|July 25, 2009
Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilitiesP Oliver-Africano, S Dickens, Z Ahmed, et al.
Toxicologic Pathology|November 18, 2011
Proceedings of the 2011 National Toxicology Program Satellite SymposiumGary Boorman, Torrie A Crabbs, Holly Kolenda-Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2012
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemiaSmriti Khanna, Sandeep Burudkar, Komal Bajaj, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
European Journal of Pharmacology|February 26, 2009
A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitisNilesh M Dagia, Divya V Kamath, Pooja Bhatt, et al.
Scientific Reports|January 26, 2023
Oceanic SACZ produces an abnormally wet 2021/2022 rainy season in South AmericaLuciano P Pezzi, Mario F L Quadro, Everaldo B Souza, et al.
Genome Research|May 31, 2001
Genetic evidence on the origins of Indian caste populationsM Bamshad, T Kivisild, W S Watkins, et al.
Health Technology Assessment (Winchester, England)|April 29, 2009
Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)P Tyrer, P Oliver-Africano, R Romeo, et al.
Tissue Antigens|July 8, 2011
Characterization of 236 novel alleles at the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci from China Marrow Donor ProgramJ Li, J Qu, X Zhang, et al.
Pageof 74